Based on my financial analysis, I would not touch Bionano Genomics (NASDAQ:BNGO) right now. I would run fast and far away from BNGO stock. But why? There are several reasons, and they all have to do ...
Genomics (TXG) has caught investor attention following recent market activity, sparking conversations about its stock performance and long-term story. Shares have moved in response, as investors ...
Genomics company Illumina (NASDAQ:ILMN) beat Wall Street’s revenue expectations in Q3 CY2025, but sales were flat year on year at $1.08 billion. Its non-GAAP profit of $1.34 per share was 14.7% above ...
New research suggests that large language models like GPT-4 could streamline the process of gene set enrichment, an approach what genes do and how they interact. Results bring science one step closer ...
BioNano Genomics Inc (NASDAQ:BNGO) shares are trading sharply lower in Tuesday’s session after the company announced the pricing of a $10 million public offering. What To Know: The company announced ...
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, and the A*STAR Genome Institute of Singapore (A*STAR GIS), today announced a research collaboration for the Target ...
Sept 14 (Reuters) - Genomics startup Parse Biosciences lost its bid to dismiss a patent-infringement lawsuit brought by rival 10x Genomics (TXG.O), opens new tab and Stanford University on Thursday, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback